Compare Mounjaro vs Wegovy Mechanisms and Get Prescribed Online
What's Best Mounjaro or Wegovy for Online Prescriptions?
When comparing what's best between Mounjaro or Wegovy through online prescription services, the key advantage lies in having both options available through a single clinical assessment. EverydayMeds' 3-minute online evaluation covers eligibility for both treatments, allowing our prescribers to recommend the most suitable option based on your medical history, BMI, and individual circumstances. This eliminates the need for separate GP appointments or multiple consultations to explore different weight management medications.
The online prescription process removes traditional barriers that might limit your treatment options. Rather than being restricted to whatever your local practice can prescribe, our GPhC-registered pharmacy (#9012878) stocks both Mounjaro and Wegovy, ensuring you can access whichever treatment your prescriber determines is most appropriate. This comprehensive approach means you're not forced to choose what's best between Mounjaro or Wegovy without professional guidance—instead, you receive personalised medical advice alongside convenient online access.
Pricing Comparison: What's Best Mounjaro or Wegovy Value?
When evaluating what's best between Mounjaro or Wegovy from a cost perspective, Wegovy pricing at EverydayMeds starts at £79.99 for the 0.25mg starter dose (with code FIRST40 for new customers). The full dose escalation includes 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and the 2.4mg maintenance dose at £209.99. Our Getting Started bundles provide convenience for the initial months, such as the Intro Duo (0.25mg & 0.5mg) for £169.99.
Returning customers can use code DOSE25 at checkout, while new customers apply FIRST40 to reach these final prices. The Consistency bundles offer supply security for patients established on their optimal dose, such as Consistency 2.4mg (×2 pens) for £419.99. Rather than deciding what's best between Mounjaro or Wegovy based solely on cost, consider that both treatments require long-term commitment, making the prescription process and reliable supply equally important factors.
Clinical Evidence: What's Best Mounjaro or Wegovy Research?
When examining what's best between Mounjaro or Wegovy based on clinical evidence, both treatments have demonstrated significant efficacy in their respective trials. Wegovy's STEP trials showed that patients taking semaglutide alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT trial additionally demonstrated a 20% reduction in major cardiovascular events.
Mounjaro's clinical programme showed similar impressive results, though direct head-to-head comparisons aren't available due to different trial designs and patient populations. Both medications work through different mechanisms—Wegovy targets GLP-1 receptors alone, while Mounjaro activates both GIP and GLP-1 receptors. Rather than determining what's best between Mounjaro or Wegovy from trial data alone, individual response and tolerability often prove more relevant for treatment success.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone produced in your intestines when you eat. This medication works by reducing appetite and promoting feelings of fullness after smaller meals, which may help you consume fewer calories throughout the day. The treatment also appears to reduce food cravings by working on brain appetite centres, particularly areas that control reward-driven eating behaviours. Wegovy is administered as a once-weekly injection using Novo Nordisk's FlexTouch pen, which many patients find convenient compared to daily medications. This prescription-only medicine must be used alongside a reduced-calorie diet and increased physical activity to achieve optimal results, as the medication enhances rather than replaces lifestyle modifications.
Online Prescription Process: 3-Minute Assessment to Delivery
Our streamlined online prescription process begins with a comprehensive 3-minute clinical assessment covering your medical history, current medications, BMI calculation, and weight management goals. This assessment evaluates eligibility for both Mounjaro and Wegovy, allowing our prescribers to recommend the most suitable option rather than requiring you to pre-select a treatment. Once submitted, a licensed UK prescriber reviews your case within our standard 3 working days, or 24 hours if you choose express service. Upon approval, your medication ships via next-day delivery using temperature-controlled cold-chain logistics to maintain the injection's stability. No GP appointment or referral is required, making this process significantly more convenient than traditional prescription routes while maintaining full clinical oversight.
Storage and Practical Considerations
Wegovy requires refrigeration at 2-8°C before first use but offers a significant practical advantage with 6 weeks of room temperature stability once removed from the fridge (provided temperatures stay below 30°C). This extended room temperature tolerance makes Wegovy more travel-friendly compared to Mounjaro's 21-day room temperature limit, which could influence your decision when considering what's best between Mounjaro or Wegovy for your lifestyle. The FlexTouch pen system is pre-filled and ready to use, with clear dose markings and an automatic needle safety system. Dose escalation follows a mandatory schedule starting at 0.25mg for weeks 1-4, increasing every 4 weeks until reaching the 2.4mg maintenance dose. Each pen contains 4 weekly doses, and the injection can be administered in your thigh, upper arm, or abdomen area. This prescription-only medicine requires proper storage and handling to maintain its effectiveness throughout the treatment period.
Why Online Prescription Works Best for Mounjaro vs Wegovy Decisions
The online prescription model particularly benefits patients comparing what's best between Mounjaro or Wegovy because it removes the pressure of making an immediate decision during a brief GP appointment. Our clinical assessment allows you to thoroughly consider your medical history, previous weight management attempts, and lifestyle factors that might influence treatment choice. This comprehensive evaluation ensures your prescriber has complete information to make evidence-based recommendations rather than defaulting to whichever medication happens to be most readily available through your local practice.
Additionally, online prescription services provide continuity of care that's especially valuable for long-term weight management treatments. Once established on either Mounjaro or Wegovy, you can reorder through the same platform with prescribers who understand your treatment history and response. This eliminates the common problem of switching between different healthcare providers who may not be familiar with your specific weight management journey, ensuring consistent care whether you're using Mounjaro or Wegovy for ongoing treatment.
Start Your Prescription Today: Both Options Available
Both Wegovy and Mounjaro are available from EverydayMeds, allowing your prescriber to determine which treatment best suits your individual circumstances after completing our clinical assessment. New customers can use discount code FIRST40 at checkout, while returning customers apply code DOSE25 to access our competitive pricing structure. Our GPhC-registered pharmacy (#9012878) maintains full stock of both medications, ensuring reliable supply regardless of which treatment you're prescribed. The decision of what's best between Mounjaro or Wegovy ultimately depends on your medical history, treatment goals, and individual response, making professional prescriber guidance essential. Visit https://everydaymeds.co.uk/collections/wegovy to begin your 3-minute assessment and receive expert guidance on the most appropriate weight management treatment for your needs.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
